Union Strong Technology, as the first diagnosis and treatment integrated AI solution company focusing on AIS prevention and first aid in China, has a complete AIS product matrix.
Union Strong Technology, as the leading integrated developer of acute Islamic stroke (AIS) intelligent diagnosis and treatment in China, announced that the company raises over CNY 100 million in Series C. This round of investment is led by Sequoia China and jointly invested by Poly Capital, Noah Capital, Shenzhen Juffett Investment and Tanzhen Venture Capital. CEC Capital acted as the exclusive financial advisor in this transaction.
In recent years, AIS has become the largest cause of death in the Chinese population. In a report released by China National Stroke Center, the overall lifetime risk of stroke in the Chinese population has ranked first in the world with 39.9%, and statistics show that the group is much younger. Even though millions of AIS cases have been clinically diagnosed and hundreds of thousands of cases have been clinically treated every year, 99% of unruptured internal aneurysms (UIA) have not been detected in the clinic, and 70% of AIS large vessel occlusion have not been effectively treated. It not only dealt a heavy blow to the patients themselves and the whole family but also brought a huge burden on the national medical insurance expenditure.
Union Strong Technology was founded in September 2016. After years of scientific research and rigorous clinical verification, it has developed an integrated intelligent diagnosis and treatment platform for hemorrhagic and ischemic AIS Based on leading artificial intelligence algorithms. The platform provides patients with cerebrovascular diseases with products and services from automatic screening, accurate diagnosis, intelligent surgical planning, intraoperative assistance, and postoperative follow-up, and comprehensively upgrades the level of AIS diagnosis and treatment in hospitals at all levels in China with the world's leading digital means.